- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03144180
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques (qcup)
Compare the Q-Cup With Other Umbilical Cord Blood Collection Techniques: A Feasibility Study
Aperçu de l'étude
Description détaillée
Approximately 4 million babies were born in the United States in 2015. Umbilical cord blood (UBC) collection is a routine hospital procedure done to evaluate a newborn's health after the birth of the fetus. UBC is tested to measure bilirubin levels, blood gases, blood sugar levels, blood types, complete blood counts, and platelet counts. UBC is collected by either draining the blood into the collection vial, milking the umbilical cord of blood, or extracting the blood by injecting a needle with a syringe. The Center for Disease Control (CDC) estimates 5.6 million workers in the health care industry are at risk of occupational exposure to bloodborne pathogens. Occupational exposure during umbilical cord blood collection may occur due to the great deal of blood and amniotic fluid present at the time of delivery. This fluid causes the physician to have a slippery grasp on the umbilical cord and vials for collection. These methods pose a risk of exposing Labor and Delivery staff to blood borne diseases. The drainage and milking method can lead to an increased amount of spilled blood while the extraction method may lead to accidental needle sticks. Exposure to bloodborne pathogens may be amplified when the umbilical cord is engorged with blood and as the needle is inserted in the cord, splatter may occur. The Needlestick Safety and Prevention Act was signed into law on November 6, 2000 in which employees were required to implement safer medical devices. Many patents have been obtained for umbilical cord blood collection devices however, there has not been a standardized method of collecting and transferring umbilical cord blood to the laboratory vacuum tubes. The goal of this project is to prove the feasibility of using the Q-Cup, a patent pending disposable, two-piece blood collection and transfer device for safely and efficiently collecting umbilical cord blood and transferring it into laboratory vacuum tubes.
The overall objective of this project is to prove the feasibility of using a two-piece umbilical blood collection and transfer device for safely and effectively collecting umbilical cord blood and transferring the blood into a laboratory vacuum tube. Also, the investigators will assess provider satisfaction, safety, ease of use, length of procedure comparing passive flow into blood tubes and the Q-cup technology. The Q-Cup technology can take part in the effort to reduce occupation exposures including percutaneous exposures during labor and delivery in general and by studying specifically the heretofore neglected category of umbilical cord blood collection and transfer. Efforts in this area will help focus attention on this previously ignored domain and help establish a standard of care and safety during this frequent procedure.
The investigators hypothesize the Q-Cup will be a more effective transfer method than current practices utilized for umbilical cord blood collection.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Texas
-
El Paso, Texas, États-Unis, 79912
- Texas Tech University Health Sciences Center El Paso
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Obstetric patients must be age 18 or older
- Obstetric patients must be receiving prenatal care at Texas Tech University Health Sciences Center El Paso Department of Ob-Gyn
- Obstetric patients must be in their third trimester
- Obstetric patients must be delivering at University Medical Center
Exclusion Criteria:
- children will not be included
- patients in active labor
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Control
The Q-cup will not be used to collect umbilical cord blood.
|
|
|
Comparateur actif: Study Group
The Q-cup will be used to collect umbilical cord blood.
|
This technology is a different way of collecting umbilical cord blood.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mean Blood Collection Time
Délai: 12 weeks
|
Anticipating the average lengths of cord blood collection with the standard method is 15 seconds and 30 seconds with the Q-cup, we needed 30 subjects total.
15 in the Q-cup arm of the study and 15 in the comparison group (for a two-sided two-sample t-test with 80% power, an alpha of 0.05, and a common standard deviation of 14 seconds).
30 participants were recruited into the study, however, the delivery providers were in charge of collecting this outcome.
|
12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Determining Umbilical Cord Collection Cleanliness With the Q-cup as Compared to the Standard Blood Collection Method
Délai: At Delivery which could be between 1 to 12 weeks after Baseline.
|
Participants' delivery providers were asked to self-administer a survey in which they were to assess blood collection for cleanliness.
Possible choices were excellent/ good or fair/poor.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
At Delivery which could be between 1 to 12 weeks after Baseline.
|
|
Fill Capacity of Umbilical Cord Blood Using the Qcup Compared to Standard of Care
Délai: 12 weeks
|
Participant delivery providers were asked to self-administer a survey in which they were to assess the fill capacity of the lab tubes using the Qcup or the standard method.
Possible choices were filled to capacity and not filled to capacity.
Some delivery providers did not fill out the surveys and therefore, data was missing.
|
12 weeks
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Michael Schaffer, MD, Texas Tech University Health Sciences Center, El Paso
Publications et liens utiles
Publications générales
Liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- E17020
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Q-cup
-
Stryker Trauma GmbHComplétéNécrose de la tête du fémur | Arthrose primaire | Luxations congénitales | Fracture du col du fémur | Arthrose post-traumatique de la hanche Nos
-
University of AarhusInscription sur invitationArthroplasties, remplacement de la hancheDanemark
-
Dedienne Sante S.A.S.ComplétéArthroplastie totale primaire de la hancheFrance
-
Holland Bloorview Kids Rehabilitation HospitalComplété
-
Kenneth PalmerUnited States Department of DefenseRecrutementPrévention COVID-19États-Unis
-
Jetema Co., Ltd.Complété
-
GlaxoSmithKlineComplété
-
Cynosure, Inc.Résilié
-
Institut Mutualiste MontsourisRecrutementFibrillation auriculaireFrance
-
Boston Scientific CorporationComplétéTachycardie ventriculaireÉtats-Unis, Pays-Bas, Nouvelle-Zélande, Royaume-Uni